Publications:

Mutations That Confer Drug-Resistance, Oncogenicity and Intrinsic Activity on the ERK MAP Kinases-Current State of the Art.

Cells

Smorodinsky-Atias, Karina K; Soudah, Nadine N; Engelberg, David D

Publication Date: 2020-01-06

Variant appearance in text: EGFR: S151D

PubMed Link: 31935908

Variant Present in the following documents:

• Main text
• cells-09-00129.pdf

View BVdb publication page

MAP4K4 is a novel MAPK/ERK pathway regulator required for lung adenocarcinoma maintenance.

Molecular Oncology

Gao, Xuan X; Chen, Guangming G; Gao, Chenxi C; Zhang, Dennis Han DH; Kuan, Shih-Fan SF; Stabile, Laura P LP; Liu, Guoxiang G; Hu, Jing J

Publication Date: 2017-06

Variant appearance in text: EGFR: S151D

PubMed Link: 28306189

Variant Present in the following documents:

• MOL2-11-628.pdf

View BVdb publication page

The Conserved MAPK Site in E(spl)-M8, an Effector of Drosophila Notch Signaling, Controls Repressor Activity during Eye Development.

Plos One

Bandyopadhyay, Mohna M; Bishop, Clifton P CP; Bidwai, Ashok P AP

Publication Date: 2016

Variant appearance in text: EGFR: S151D

PubMed Link: 27428327

Variant Present in the following documents:

• Main text
• pone.0159508.pdf

View BVdb publication page